FILE PHOTO: Illustration shows GSK (GlaxoSmithKline) logo FILE PHOTO: GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Post navigation Previous: GSK’s RSV vaccine shows long-term efficacy in late-stage trial